Pharmacodynamics and pharmacokinetics of the novel thrombopoietin mimetic peptide RWJ-800088 in humans.
about
Pharmacokinetic and pharmacodynamic modeling of pegylated thrombopoietin mimetic peptide (PEG-TPOm) after single intravenous dose administration in healthy subjects.Current treatment options for primary immune thrombocytopenia.Nonclinical safety assessment of a synthetic peptide thrombopoietin agonist: effects on platelets, bone homeostasis, and immunogenicity and the implications for clinical safety monitoring of adverse bone effects.
P2860
Pharmacodynamics and pharmacokinetics of the novel thrombopoietin mimetic peptide RWJ-800088 in humans.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Pharmacodynamics and pharmacok ...... peptide RWJ-800088 in humans.
@ast
Pharmacodynamics and pharmacok ...... peptide RWJ-800088 in humans.
@en
type
label
Pharmacodynamics and pharmacok ...... peptide RWJ-800088 in humans.
@ast
Pharmacodynamics and pharmacok ...... peptide RWJ-800088 in humans.
@en
prefLabel
Pharmacodynamics and pharmacok ...... peptide RWJ-800088 in humans.
@ast
Pharmacodynamics and pharmacok ...... peptide RWJ-800088 in humans.
@en
P2093
P2860
P356
P1476
Pharmacodynamics and pharmacok ...... c peptide RWJ-800088 in humans
@en
P2093
J Burggraaf
M L de Kam
M Liem-Moolenaar
Y van Hensbergen
P2860
P304
P356
10.1038/CLPT.2008.96
P407
P577
2008-10-01T00:00:00Z